LOS ANGELES, CA / ACCESSWIRE / August 26, 2019 / Tech Central, Inc. (OTC PINK:TCHC) entered the CBD market in 2019 with an approach that not only included launching its own CBD products, but also includes helping burgeoning businesses build their exclusive CBD brand in the industry as well.

In a short amount of time the company has announced the development of its “CBD Affiliate Marketer” app, launched its “Better Mind CBD” line of products, created a white-label division as part of the Better Mind CBD business for customers who are interested in creating their very own CBD brand, and just this month, Tech Central announced that it has entered into a new retail partnership for its CBD line.

One look at the growth around the world in the legal cannabis industry and it’s pretty clear why Tech Central is navigating its way into this space. One key driver that company executives have identified for the growth is the signing of the 2018 Farm Bill. Additionally, another driver of note is the growing number of countries that are decriminalizing cannabis and legalizing the use of marijuana for both medical and recreational uses, which has broadened the industry quickly on the worldwide stage.

A number of industry experts and research firms have weighed in on the cannabis market’s growth and its effect on sales in the U.S. and abroad. Hemp-derived cannabidiol (CBD) alone could become a $22-billion market by 2022, according to Brightfield Group, while the marijuana market could one day reach $166 billion in annual sales, according to Bank of America.

In this arena, Tech Central is creating a “one-stop shop” of sorts for clients while creating what is an obvious “start-to-finish solution” for both itself and for any new businesses that have an interest in entering the extremely popular CBD industry.

Recent Updates

First, In recent Company news Joseph Lewis, President of Tech Central, stated that the company has entered into a partnership and received a purchase order from Mountain High Products, Inc. According to the terms of the deal, Mountain High Products will distribute Tech Central’s Better Mind CBD products at several retail outlets.

Second, the company’s Better Mind CBD (www.bettermindcbd.com) products, which are already gaining traction as evidenced by the aforementioned deal with Mountain High Products, are a high-end CBD line using proprietary formulas for sleep, anxiety, inflammation and stress. Tech Central plans to market Better Mind CBD throughout the U.S. and Canada, while at the same time, continuing to expand its current product line. Tech Central expects to start generating revenues related to its Better Mind CBD product line during the current quarter-Q3 2019.

Next, the company’s white-label division, which was created as a division of Better Mind CBD, is for any customer who may desire starting their own brand. Tech Central is providing an opportunity for customers to experience what is essentially a one-stop shop on their way to developing their own CBD brand. White label clients can select existing CBD products from the company’s catalog, or they can develop custom formulas of their own using a “formulator.” Once the customer finalizes their formulas, Tech Central has a design team that will work with the client every step of the way to create a compliant label that best represents their brand.

Joseph Lewis said of the white label division, “We saw right away that white labeling was going to be an important service to offer to our customers. Tech Central has the ability to stand out in the crowd since Better Mind CBD will not only be able to offer white label services, but also services Tech Central has been doing for years such as label development, website development, and media creation to its clients.”

And finally, Tech Central is developing an app that is solely dedicated to affiliate marketers in the CBD industry. “CBD Affiliate Marketer” is the name of the app, and it will provide training and resources to new and established affiliate marketers who desire to market their products in the CBD industry-especially in hard to advertise mediums such as Facebook and Google. The company believes that the app is a natural fit for Better Mind CBD to also grow its sales.

With its expertise and ability to market, Tech Central believes it will have no problem generating revenue, especially in a market that, as stated earlier, experts and research firms are extremely bullish on and expect to flourish well into the future.

Worldwide legal cannabis spending hit $12.2 billion in 2018, and according to Arcview Market Research and its research partner BDS Analytics, the industry is projected to grow another 38% to $16.9 billion by the end of 2019. This is a significant jump from $9.5 billion in 2017-just two short years ago.

In their published research report, The State of Legal Marijuana Markets, Arcview and BDS expect spending on legal cannabis to balloon to an incredible $57 billion worldwide by 2027. Meanwhile, Cowen, Inc., a financial services and research firm covering the cannabis industry, is much more bullish on sales in this space and has revised its forecast for gross cannabis sales in the U.S. alone from $50 billion by 2026 to around $75 billion in gross sales by 2030. And then there is Grand View Research, Inc., who published a report that forecasts the global legal marijuana market to reach $146.4 billion by years-end 2025.

Joseph Lewis further stated “There is plenty of opportunity in the CBD industry. As Tech Central continues to define and shape its business model, it will also compete for its place in what is sure to be a very lucrative industry for a long time to come.”

Learn more about Tech Central, Inc. and its move into CBD industry at: www.techcentralinc.com and www.bettermindcbd.com.

About Tech Central

Tech Central, Inc. (TCHC) is a media company engaging in online video, photography, content development and distribution; and website and mobile app technology integration design and development.

The Company entered the cannabis sector using its APP, Media and Web development background to launch its own line of original products called Better Mind CBD in addition to white label capabilities. Tech Central plans to integrate its already existing business of app development and content development into the CBD Company to provide white label clients with a one-stop shop for creating their own CBD brand.

Disclosure

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Tech Central Inc (TCHC) is under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Joseph Lewis
Chief Executive Officer
Email: Joe@techcentralinc.com

Better Mind CBD Contact
info@bettermindcbd.com

SOURCE: Tech Central, Inc.

ReleaseID: 557409

NEW YORK, NY / ACCESSWIRE / August 26, 2019 / VitaminEnergy®, the healthy, on-the-go functional energy shots, recently appointed Tim Duncan as their new Regional Vice President of Sales of Drug & Grocery Chains.

In his new role, he will be responsible for expanding the VitaminEnergy® brand reach to customer in the Drug and Grocery classes of trade in the Northeast and Midwest.

Duncan joins VitaminEnergy® from Strategic Sales and Marketing, where he contracted with emerging companies as a consultant by helping them to become retail ready and bring their products the mass retail channels of distribution. He also served many national supplier companies as their broker selling products to convenience store, grocery, drug, mass retail and military retailers. Duncan comes to VitaminEnergy® with over twenty years sales, operations and marketing experience in various management positions, including management of personnel, retail trade marketing and wholesale trade and brand development with American Greetings, Service Advantage, Advantage Solutions and Navajo.

“Vitamin Energy presents an exciting and unique opportunity for me to utilize my experience in sales and marketing to bring an impressive and stimulating new product to an established category”, says Duncan. VitaminEnergy® is FUNCTIONAL ENERGY that delivers more to the consumer than a burst of pep. The same 2-ounce shot, in addition to energy, provides a supply of Vitamin C equal to more than 10 oranges, or infused with Vitamin B-12 pulled from 14,000% of B-12 Vitamin or an energy shot with recovery power and pain relief from CBD.”

Tim Duncan joins the senior management team of Vitamin Energy, LLC which is led by CEO and co-founder Nick Mihnovets; VP of Business Development, Larry Greenway; and VP of Sales, Philip Gates.

About VitaminEnergy®

Vitamin Energy LLC is the maker of VitaminEnergy® Functional Energy Shots. Vitamin Energy LLC products are available through various distributors including Core-Mark, McLane, HT Hackney, GSC, MR Williams as well as many reginal distributors. The term “Energy, with Benefit™” has been trademarked to support their position as an energy shot that provides additional functions.

For media inquiries please email support@vitaminenergyllc.com

SOURCE: Vitamin Energy, LLC

ReleaseID: 557410

INCLINE VILLAGE, NV / ACCESSWIRE / August 26, 2019 / American Battery Metals Corporation (OTCQB:ABML) (the “Company”), a premier battery metal exploration and development company based in Nevada, today announced it has established a company office in Tonopah, Nevada.

The new location will provide various strategic benefits, serving as a venue for research and analysis, storage, and as an auxiliary testing facility. American Battery Metals Corporation Chief Executive Officer Doug Cole, stated, “As we continue to scale our mining, extraction, battery recycling and distressed asset acquisition operations, it made sense to expand our physical footprint in Nevada.”

Cole continued, “This additional office space complements our Incline Village office as well as our full chemical laboratory in Virginia City, providing company personnel with multiple locations from which to conduct company business.”

Tonopah, NV is just 55 miles south of the company’s 1300 claims in Railroad Valley, NV.

American Battery Metals Corporation

American Battery Metals Corporation (www.batterymetals.com) (OTCQB:ABML) is a premier battery metal exploration and development company based in Nevada. The company is focused on its Railroad Valley battery metal project in Nevada with the goal of becoming a substantial domestic supplier of battery metals to the increasing electric vehicles and battery storage markets in America.

For more information, please visit: www.batterymetals.com

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected project economics for Western Nevada Basin (Railroad Valley), including estimates of life of mine, average production, cash costs, AISC, initial CAPEX, sustaining CAPEX, pre-tax IRR, pre-tax NPV, net cash flows and recovery rates, the impact of self-mining versus contract mining, the timing to obtain necessary permits, the submission of the project for final investment approval and the timing of initial gold production after investment approval and full financing, metallurgy and processing expectations, the mineral resource estimate, expectations regarding the ability to expand the mineral resource through future drilling, ongoing work to be conducted at the Western Nevada Basin (Railroad Valley), and the potential results of such efforts, the potential commissioning of a Pre-Feasibility study and the effects on timing of the project, are “forward-looking statements.” Although the Company’s management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties, which could cause the Company’s future results to differ materially from those anticipated. Potential risks and uncertainties include, among others, interpretations or reinterpretations of geologic information, unfavorable exploration results, inability to obtain permits required for future exploration, development or production, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; fluctuating mineral and commodity prices, final investment approval and the ability to obtain necessary financing on acceptable terms or at all. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended September 30, 2018. The Company assumes no obligation to update any of the information contained or referenced in this press release.

Contact Information

Phone: 775-473-4744
Email:info@batterymetals.com

SOURCE: American Battery Metals Corp.

ReleaseID: 557402

Company’s Legacy Animal Health Business Supports Focus on Human Health Benefits

SAN FRANCISCO, CA / ACCESSWIRE / August 26, 2019 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) announced today that the Company is scheduled to meet with the U.S. Food & Drug Administration’s Center for Veterinary Medicine (CVM) on September 11, 2019 to conduct a pre-submission conference about the Company’s plans to evaluate crofelemer for exercise-induced diarrhea (EID) in dogs.

To expedite the submission and application process for the EID indication, Jaguar will be leveraging use of the same four major technical sections for EID that have been or will be submitted in support of the Company’s application for crofelemer delayed-release tablets (Canalevia™) for the indication of chemotherapy-induced diarrhea (CID) in dogs, which is proceeding on a parallel development path in support of conditional approval.

As announced June 19, 2019, the Target Animal Safety technical section, which is the last of the four technical sections Jaguar is required to file for the proposed CID indication, is expected to be submitted to CVM in the third quarter of 2019.

“We believe dog experience, such as the recent crofelemer study in dogs with an FDA-approved human tyrosine kinase inhibitor (TKI), is predictive of the expected benefit of crofelemer in human patients suffering from cancer therapy-related diarrhea. With receipt of conditional approval for CID, the Company expects the product to be commercially available for this indication in dogs in the first half of 2020,” Lisa Conte, Jaguar’s president and CEO, stated.

EID is a common problem among working dogs, such as sled dogs and military dogs, when subjected to periods of intense, long-duration off-leash exercise.

“Elite athletes of all species tend to have more diarrhea than their healthy but more sedentary counterparts, and while the episodes of diarrhea may not be life-threatening, they are nevertheless significant if the goal is peak physical performance. Thus, there is a considerable need in the world of working dogs for products that can reduce the incidence and severity of exercise-induced diarrhea without affecting performance,” commented Dr. Michael Davis, DVM, Ph.D., DACVIM, DACVSMR, a veterinary physiologist and board-certified specialist in veterinary internal medicine and veterinary sports medicine at Oklahoma State University, where he conducts research on animal exercise physiology and performance.

About Crofelemer

Crofelemer, the active pharmaceutical ingredient being tested, is a botanical (plant-based) drug extracted and purified from the red bark sap of the medicinal Croton lechleri tree in the Amazon rainforest. Napo has established a sustainable harvesting program for crofelemer to ensure a high degree of quality and ecological integrity.

About Jaguar Health, Inc.

Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

For more information about Jaguar, please visit jaguar.health. For more information about Napo, visit napopharma.com.

Forward-Looking Statements

Certain statements in this press release constitute “forward-looking statements.” These include statements regarding the expectation that the Company will meet with CVM on September 11, 2019, the expectation that the Target Animal Safety technical section of the Company’s application for conditional approval of Canalevia for CID in dogs will be submitted to CVM in the third quarter of 2019, the belief that dog experience, such as the recent crofelemer study in dogs with an FDA-approved human TKI, is predictive of the expected benefit of crofelemer in human patients suffering from cancer therapy-related diarrhea, and the expectation that the Company will conduct the commercial launch of Canalevia for CID in dogs, if the Company receives conditional approval for this indication, in the first half of 2020. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “aim,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar’s control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contact:

Peter Hodge
Jaguar Health, Inc.
phodge@jaguar.health
Jaguar-JAGX

SOURCE: Jaguar Health, Inc.

ReleaseID: 557392

TORONTO, ON / ACCESSWIRE / August 26, 2019 / RIWI Corp. (CSE:RIW)(OTC PINK:RWCRF) (the “Company” or “RIWI”), a global trend-tracking and prediction technology firm, is pleased to announce that it has been selected to present at the fourth annual MicroCap Leadership Summit, hosted by MicroCapClub, on Friday, September 27, 2019, at the Westin Chicago Northwest Hotel in Itasca, Illinois, and also at the 11th annual TEDx Toronto event on Saturday, October 26, 2019, at Toronto’s Evergreen Brick Works.

Neil Seeman, RIWI’s Chief Executive Officer and Daniel Im, RIWI’s Chief Financial Officer, will deliver the MicroCap presentation. The MicroCap Leadership Summit utilizes a small group format whereby the Company will present to retail and institutional investors throughout the day. Concurrently with the presentation on September 27, 2019, RIWI’s updated investor presentation will be accessible on the “Investors” page of the RIWI website, located at https://riwi.com/investor-info/.

For more information about the MicroCap Leadership Summit, please visit http://microcapclub.com/summit.

Danielle Goldfarb, RIWI’s Head of Global Research, will be speaking at TEDx Toronto on October 26, 2019. Ms. Goldfarb will argue that the most critical, predictive insights come from people left out of most behavioral and opinion data. Her talk will discuss how RIWI technology accesses these disengaged voices to better predict election and referenda results, economic inflection points, and social unrest.

For more information about TEDx Toronto, please visit https://tedxtoronto.com/.

About RIWI

RIWI is a global trend-tracking and prediction technology firm. On a monthly or annual subscription basis, RIWI offers its clients tracking surveys, continuous risk monitoring, predictive analytics and ad effectiveness tests in all countries – without collecting any personally identifiable data. https://riwi.com.

About MicroCapClub

MicroCapClub is an exclusive forum for experienced microcap investors focused on microcap companies (below US$300 Million market capitalization) trading on United States, Canadian, European, and Australian equity marketplaces. MicroCapClub was created to be a platform for experienced microcap investors to share and discuss stock ideas. Investors can join our community by applying to become a member or subscribing to gain instant view-only access. MicroCapClub’s mission is to foster the highest quality microcap investor community, produce educational content for investors, and promote better leadership in the microcap arena. For more information, visit http://microcapclub.com

RIWI CORP.

Signed: “Neil Seeman”
Neil Seeman, Chief Executive Officer

For more information, please contact:

Daniel Im, Chief Financial Officer
danielim@riwi.com
+1-416-205-9984 ext. 2
https://riwi.com

SOURCE: RIWI Corp.

ReleaseID: 557371

LOS ANGELES, CA / ACCESSWIRE / August 26, 2019 / Compare-autoinsurance.org has launched a new blog post that explains how first-time drivers can get car insurance.

For more info and free car insurance quotes online, visit https://compare-autoinsurance.org/how-to-insure-first-time-drivers/

For new drivers, buying their first car insurance policy could be a nightmare if they don’t know where to look and what to ask. First-time drivers should follow the next steps searching for car insurance.

Drivers should know that every state requires some form of minimal financial responsibility. Most states require a minimum liability car insurance, while some states will allow drivers to prove their financial responsibility via a bond or certificate of deposit.
Determine what insurance they need. There are many factors for a new driver to analyze when he decides how much coverage he needs. Factors like how much is his net worth, how much he owes or he is own, and how much he can afford to pay out-of-pocket if he causes an accident. If a driver has additional significant assets, like a house or another vehicle, he is recommended to buy additional coverage that will protect his assets in case of a lawsuit. In many states, the minimum liability insurance is not enough to pay for serious injuries or to replace expensive cars.
Before buying car insurance, new drivers should get several quotes from different insurance providers and see what offer suits them the best.

For additional info, money-saving tips and free car insurance quotes, visit https://compare-autoinsurance.org/

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

“First-time drivers can get really affordable car insurance rates if they are properly guided”, said Russell Rabichev, Marketing Director of Internet Marketing Company.

Company Name: Internet Marketing Company
Person for contact Name: Gurgu C
Phone Number: (818) 359-3898
Email: cgurgu@internetmarketingcompany.biz
Website: https://compare-autoinsurance.org/

SOURCE: Internet Marketing Company

ReleaseID: 557403

NEW YORK, NY / ACCESSWIRE / August 26, 2019 / ​​​​​​SportsGrid, the nation’s first and only 24-hour network for the sports, gaming audience will launch today on XUMO, the leading free, ad-supported TV (FAST) service. Available on channel 719, XUMO users will have access to SportsGrid’s real-time convergence of live expert analysis with key statistics and gaming intelligence for sports enthusiasts.

SportsGrid Founder and President Louis M. Maione said, “With the start of the new NFL and College Football seasons, SportsGrid’s launch on XUMO is well-timed to connect with the fanatical sports audience. The network will take full advantage of the production studios to create live audio and video content around gambling and will engage fans on gameday like never before.”

“Linear, live programming is easy to watch and perfect for this core, loyal audience,” said XUMO’s head of partnerships and programming, Stefan Van Engen. “Consumption of the sports genre has increased by an average of 8 percent month over month and we are excited to watch that number grow with the new programming SportsGrid is bringing to XUMO.”

The network schedule offers 18 hours of live, original programming daily with coverage of the NFL, NBA, MLB, NHL, college sports, Tennis and Soccer. The odds, matchups, injury reports, news and more with expert analysts originating from the state-of-the-art television production facilities located in New York City adjacent to Madison Square Garden and at the Meadowlands inside the FanDuel Sportsbook.

Jeff Gural, Chairman & CEO of Meadowlands Racing and Entertainment added, “Programming goes where the audience is, and the FanDuel Sportsbook at The Meadowlands is the destination for the sports betting community. We’re excited to support SportsGrid and their assets to bring a new dimension to the coverage of the sports betting experience.”

About SportsGrid Inc.

SportsGrid is a digital-first linear video network streaming exclusive live original programming providing extensive sports gambling coverage of all the major sports. The network’s 18 hours of live programming gives the fanatical sports betting fan the news, scores, odds, rumors, match-ups and insightful expert commentary. The SportsGrid strategic partnership with Sportradar enables the network to integrate their real-time delivery of player and team news, data, statistics and betting intelligence into all the programming on the schedule. SportsGrid is the multimedia destination to serve the massive sports betting audience with the unquestionable best of breed sports wagering programming and data.

ABOUT XUMO

A pioneer in streaming television and media entertainment, XUMO offers over 170 digital channels of free premium programming across 12 genres, including Sports, News, Kids and Family Entertainment, Live Events, Comedy, Lifestyle, Movies, and more. The free, ad-supported service is available in 35 million U.S. households via a multi-screen distribution network of smart TVs, mobile, web and streaming boxes. XUMO delivers its over-the-top (OTT) video-on-demand (VOD) and LIVE linear digital channels through content partnerships with popular media providers such as CBSN, PeopleTV, NBC News, Food52, and HISTORY, as well PGA TOUR, and many others. The company is based in Irvine, CA. Learn more about XUMO at www.xumo.tv and follow @XumoTV on Twitter.

Contact:

SportsGrid
Charles Theiss
+1 (914) 843-1414
comms@sportsgrid.com

Additional Links
SportsGrid
XUMO

SOURCE: SportsGrid Inc.

ReleaseID: 557393

SAN DIEGO, CA / ACCESSWIRE / August 26, 2019 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Casa Systems, Inc. (NASDAQ:CASA) shares.

Investors, who purchased shares of Casa Systems, Inc. (NASDAQ:CASA) at $25 per share in the secondary offering that closed on April 30, 2019, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

Andover, MA based Casa Systems, Inc. provides software-centric broadband products in North America, Latin America, the Asia-Pacific, Europe, the Middle East, and Africa. Casa Systems, Inc. went public in December 2017. It sold 6 million shares at $13.00 per share in its initial public offering.

The plaintiff alleges that Casa Systems’ registration documents stated that its core CCAP products and new technology initiatives would allow for a compelling market opportunity and touted the fact that these initiatives would prompt Casa Systems to experience continued rapid growth, while in reality these documents were false and misleading as Casa Systems failed to disclose material information about the state of its customers’ spending. The plaintiff claims that Casa Systems knew its key customers’ spending had entered a “digestion” period that curtailed any new product purchases.

On April 23, 2018, Casa Systems filed its Registration Statement for its secondary public offering (“SPO”) and on April 27, 2018, the Company filed its Prospectus with the SEC. On April 27, 2018, Casa Systems priced the SPO at $25.00 per share and offered to the public over 7 million Casa Systems shares.

On August 14, 2018, Casa Systems announced financial results and cut its revenue guidance for the year by $50 million.

Since then, shares of Casa Systems (NASDAQ:CASA) declined to as low as $5.46 per share on June 7, 2019.

Those, who purchased shares of Casa Systems, Inc. (NASDAQ:CASA) at $25 per share in the secondary offering that closed on April 30, 2019, should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

SOURCE: Shareholders Foundation, Inc.

ReleaseID: 557401

TORONTO, ONTARIO / ACCESSWIRE / August 26, 2019 / Seven Aces Limited (formerly Quantum International Income Corp.) (the “Company”) (TSXV:ACES) is pleased to announce that its 70% owned subsidiary, Lucky Bucks, LLC (“Lucky Bucks”), has acquired five location contracts from Ambaji Amusement LLC, a digital skill-based gaming terminal operator based in the U.S. State of Georgia, in exchange for cash consideration of US$3,252,909 (the “Acquisition”).

The purchase price for the Acquisition was funded by Lucky Bucks through an advance under the senior secured credit facility described in the press release of the Company dated November 15, 2018 and titled “Quantum Announces Increase in Credit Facility to US$100 million; Other Corporate Updates”. The gaming contracts that have been acquired are fully licensed and governed by the Georgia Lottery Corporation, and offer players a variety of skill-based coin-operated amusement machines.

The Acquisition was completed pursuant to a purchase agreement dated August 23, 2019 among Lucky Bucks and Ambaji Amusement LLC and Karan Desai which will be available on SEDAR (www.sedar.com) under the Company’s issuer profile.

Normal Course Issuer Bid

The Corporation also announces that as at August 23, 2019 it has repurchased 3,514,550 common shares under its normal course issuer bid (“NCIB”) at an average price of $0.8538. The Corporation received approval from the Exchange to commence the NCIB on February 19, 2019 as announced in the press release on February 15, 2019.

About Seven Aces Limited

Seven Aces Limited (formerly Quantum International Income Corp.) is a gaming company, with a vision of building a diversified portfolio of world class gaming operations. The Company looks to enhance shareholder value by growing organically and through acquisitions. Currently, the Company is the largest route operator of skill-based gaming machines in the State of Georgia, United States of America.

For more information about the Company is available online at www.sevenaces.com.

For further information please contact Quantum:

Manish Grigo
Vice President, Corporate Affairs
Tel. (416) 569-3292
manish@sevenaces.com

Stephanie Lippa
Office Manager
Tel. (416) 477-3411
stephanie@sevenaces.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Cautionary Statement Regarding Forward-Looking Information

This news release may contain forward-looking statements or “forward-looking information” within the meaning of applicable Canadian securities laws (“forward-looking statements”). Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved.

All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements. The key assumptions that have been made in connection with the forward-looking statements include the following: the digital gaming terminals being fully-licensed by the Georgia Lottery Corporation, the continuation of the Company’s consolidation strategy in the Georgia gaming market, the growing footprint of Quantum in the Georgia gaming market, generating value for the shareholders of the Company, the regulatory regime governing the business of Quantum in Georgia, the exchange rate between the U.S. dollar and Canadian dollar, the ability to grow the business and delivering returns for shareholders, the availability of high growth, high margin opportunities, continue adding high performing locations and the execution of the Company’s business strategy and acquisition pipeline.

Forward-looking statements involve known and unknown risks, future events, conditions, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, prediction, projection, forecast, performance or achievements expressed or implied by the forward-looking statements. Such factors include, among others, the Company’s ability to continuing to execute a growth strategy through acquisitions; and the Company’s ability to generate higher margins and significant growth in cash flows. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

SOURCE: Seven Aces Limited

ReleaseID: 557387

DENVER, CO / ACCESSWIRE / August 26, 2019 / Tamarack Advisors recently sat down with Dennis Calvert, the CEO of BioLargo, Inc. (OTCQB:BLGO) to discuss their recent news and corporate developments.

Q: Over the last couple of months trading volume and share price for BioLargo have increased significantly. To what would you attribute this recent surge in interest in BLGO?

A: I think investors are starting to realize that BioLargo is well positioned for growth and financial success. We have achieved a number of important and high-value milestones. With basic due diligence, investors easily conclude that BioLargo has managed to conceive, develop, patent, prove, finance and is now actively commercializing a robust portfolio of sustainable and disruptive technologies and products focused on clean air, clean water, advanced wound care. In each of these areas, we have focused on technical innovations that we believe are the #1 technical solutions for the target problems. With the addition of BioLargo Engineering Science and Technologies, (BLEST) and the build out of our full services, design, construction, installation, service and maintenance teams at Odor No More, we can now offer customers both innovation and full-service solutions to some of the most difficult environmental and health related issues. Consider just a few of our most recent developments:

BioLargo Engineering (BLEST) landed contracts to serve seven United States Air Force bases focused on air quality
BLEST was awarded a “small business innovation research” grant by the EPA to tackle the removal of PFAS contamination from water (PFAS are fluorinated compounds considered one of the most pressing contamination issues of the past decade)
Begun selling products under our fourth “National Purchasing Agreement” with the largest waste handling companies in North America
Hired a former senior executive of a leading waste handling company to expand and grow sales of our odor control products
A third-party study confirmed CupriDyne Clean eliminates odors from marijuana and hemp growing and production operations
Successfully launched 2 pilots for the AOS clean water solution
Secured its 69th grant including funding to begin its third demonstration pilot in southern California to treat stormwater for its AOS
Secured new capital totaling more than $2.6 million
Refinanced or converted over $1.3 million in current liabilities

Q: The BLGO engineering division was recently awarded subcontracts to provide air quality engineering services to seven US Air Force bases. With a foot now in the door, what kind of potential is there for future contracts at US military bases?

A: We believe there is significant potential for future contracts with other Air Force bases (as well as other branches of the armed services), and we have multiple bids outstanding and more in process.

Q: Cannabis is a relatively new industry segment for BioLargo and its Odor and VOC products, tell us how you are making progress.

A: We secured our first distributor back in April of this year, with Mabre Air Systems, Inc. and their new operating unit Cannabusters, Inc. They are busy marketing the product and services across North America, including 2-3 trade show exhibits a month, and, the have reported recent success with customers in first commercial trials, its first system install, as well as a number of distributor relationships that are developing. We recently secured proof of claim for our product capabilities eliminating the odorous terpenes (gases) associated with cannabis and hemp production and processing (Link Here). We are working with Cannabusters to finely tune the product and services offering as we both find our way through this dynamic industry. With 15,000 licensing operators in California alone, we believe this is a very large and important opportunity. We have a great solution for this market!

Q: Regarding water treatment – BioLargo is currently conducting a live test of your AOS product on a poultry farm in Alberta, do you anticipate commercialization of the AOS soon?

A: The short answer is yes – this poultry process water demonstration pilot, which was recently featured in a short video, (video link), and the other pilot we have ongoing at a microbrewery in SoCal as well as the new project to treat captured stormwater in SoCal that just received a funding commitment , all combine to establish a cornerstone moment in the development cycle of the AOS. Demonstrating that your new technology works and has a strong economic value proposition in the field is a critical step for the development of any new, innovative technology, and that’s why this step is so important for our AOS. Once our demonstration pilots have concluded we’re moving on to commercial trials, manufacturing, then first sales. It’s hard to forecast an exact number of months until the technology is monetized, but we are getting very close, and for that reason we (and our stakeholders) are very excited for the AOS.

Q: Could you give us an update on your Clyra medical division and where you are in the FDA approval process?

A: Clyra is in the final stages of a current FDA application for pre-market clearance under 510(k). Our final task from the FDA was to demonstrate that the product does not interfere with normal wound healing processes. This was done through an animal study, and the work was recently and successfully completed. The testing laboratory has completed its formal report and we are readying to submit our final written response to the FDA. Once that is done, the FDA has a limited time to approve, or reject, our application. We are not aware of anything that would result in a rejection.

We are also excited about Clyra’s SkinDisc technology, which has been tested in over 250 patient cases and has successfully aided in the salvage of limbs that otherwise would have been amputated. The regenerative tissue therapy technique has been shown to assist in successful wound closure in time frames as short at 4 to 7 weeks with one or two applications and is patent pending.

Question: Any closing remarks?

A: We are better capitalized now that we have ever been, and we intend to use these resources to grow our company and increase our revenues as well as continue to strengthen our balance sheet. We have multiple winners in our portfolio and have never been more excited about our future.

About BioLargo, Inc.

BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to “make life better” by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from “cradle” to “maturity” (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System “AOS,” a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information

Dennis Calvert President and CEO BioLargo, Inc. 949-643-9540 x2

Safe Harbor Act

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

About Tamarack Advisors

Founded in 2016, Tamarack Advisors offers a comprehensive, fully integrated suite of digital marketing services. At Tamarack Advisors we are innovators at finding, creating, and sustaining audiences for public microcap companies and private emerging growth companies. For more information please visit our website.

SOURCE: Tamarack Advisors

ReleaseID: 557398